Latest news
Castle Biosciences (CSTL) Stock Climbs On Higher Sales Outlook Despite Margin Pressure - simplywall.stsimplywall.st · Sat, 01 Aug 2026 01:38:15 GMTCSTL (CSTL) insider schedules potential $630,000 sale of 22,500 shares - Stock TitanStock Titan · Fri, 31 Jul 2026 20:53:16 GMTCastle Biosciences reports Q2 EPS (7c), consensus (41c) - TipRanksTipRanks · Fri, 31 Jul 2026 09:18:44 GMTCastle Biosciences Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 30 Jul 2026 22:04:07 GMTIs Castle Biosciences (CSTL) Undervalued After Q2 Earnings Miss? GF Score: 81/100, Revenue at $103.5 Million - GuruFocusGuruFocus · Thu, 30 Jul 2026 20:49:36 GMTCastle Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Thu, 30 Jul 2026 20:09:00 GMTCastle Biosciences Reports Second Quarter 2026 Results - PR NewswirePR Newswire · Thu, 30 Jul 2026 20:05:00 GMTCastle Biosciences 2026: Revenue $103.55M, EPS ($0.07) — 10-Q Summary - TradingViewTradingView · Thu, 30 Jul 2026 07:00:00 GMT